Pharmerica Corp is engaged in providing pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting, and offers national oncology pharmacy in the United States.
Company profile
Website
CEO
Gregory S. Weishar
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Safari Holding Corp
SEC CIK
Corporate docs
IRS number
870792558
Latest filings (excl ownership)
15-12B
Securities registration termination
18 Dec 17
25-NSE
Exchange delisting
8 Dec 17
8-K
KKR Completes Acquisition of PharMerica
7 Dec 17
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Dec 17
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Dec 17
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Dec 17
10-Q
2017 Q3
Quarterly report
9 Nov 17
8-K
Pharmerica Reports Third Quarter 2017 Results
9 Nov 17
8-K
PharMerica Announces Approval of Merger by Stockholders
9 Nov 17
8-K
Other Events
27 Oct 17
Latest ownership filings
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|